Global Pertussis Vaccine Supply, Demand and Key Producers, 2026-2032
The global Pertussis Vaccine market size is expected to reach $ 7744 million by 2032, rising at a market growth of 3.4% CAGR during the forecast period (2026-2032).
In 2024, global Pertussis Vaccine production reached approximately 350 million doses, with an average global market price of around US$ 16 per square meter. Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective. In this report, we cover all the pertussis-containing vaccines. Gross margin for the Pertussis vaccine in general shows that manufacturers often achieve roughly 50–70% gross margins, depending on the producer, country, and contract.
The global pertussis vaccine market continues to grow steadily, driven by rising awareness of whooping cough, expanding childhood immunization programs, and increasing recommendations for adolescent and adult Tdap boosters. Demand is especially strong in developing regions where pertussis remains endemic, while mature markets are supported by routine pregnancy immunization and periodic booster campaigns. Major manufacturers focus on improving vaccine safety, supply stability, and combination formulations such as DTaP, which simplify national immunization schedules. Although pricing and procurement are heavily influenced by government tenders and international organizations, overall market growth is supported by public-health initiatives, technological advances in acellular vaccine production, and efforts to increase global vaccination coverage. The pertussis vaccine industrial chain is a complex, highly regulated, and technology-intensive ecosystem that spans from upstream antigen research to downstream global immunization delivery. It is characterized by significant barriers to entry, stringent quality control, and a delicate balance between public health objectives and commercial viability. The chain begins with basic and applied research into Bordetella pertussis antigens. This includes the identification, genetic sequencing, and optimization of key immunogenic components such as Pertussis Toxin (PT), Filamentous Hemagglutinin (FHA), Pertactin (PRN), and Fimbrial proteins (FIM). For acellular vaccines (aP), the upstream segment involves mastering large-scale fermentation, toxin purification, and detoxification (converting PT to Toxoid) processes. This stage also encompasses the production of specialized adjuvants (e.g., aluminum salts) and critical raw materials for cell culture media and buffers. Innovation here focuses on improving antigen yield, purity, stability, and developing novel adjuvant systems to enhance and prolong immunity. The demand for pertussis vaccines is driven by the persistent prevalence of whooping cough, growing awareness of immunization benefits, and expanding vaccination programs for infants, adolescents, and adults. Rising adoption of Tdap boosters during pregnancy and among healthcare workers further fuels market growth. Opportunities exist in developing countries where vaccination coverage is still limited, as well as in urban areas of developed nations with increasing focus on adult immunization and combination vaccines like DTaP to simplify schedules. Additionally, technological innovations in acellular vaccine production, improvements in cold-chain logistics, and government-supported public health initiatives create potential for new market entrants and partnerships. Manufacturers that can offer safe, effective, and easily deployable vaccines, along with reliable supply chains, are well-positioned to capture market share in both emerging and mature markets.
This report studies the global Pertussis Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pertussis Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pertussis Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pertussis Vaccine total production and demand, 2021-2032, (M Doses)
Global Pertussis Vaccine total production value, 2021-2032, (USD Million)
Global Pertussis Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Doses), (based on production site)
Global Pertussis Vaccine consumption by region & country, CAGR, 2021-2032 & (M Doses)
U.S. VS China: Pertussis Vaccine domestic production, consumption, key domestic manufacturers and share
Global Pertussis Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Doses)
Global Pertussis Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
Global Pertussis Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
This report profiles key players in the global Pertussis Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pertussis Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/Doses) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pertussis Vaccine Market, By Region:
1. How big is the global Pertussis Vaccine market?
2. What is the demand of the global Pertussis Vaccine market?
3. What is the year over year growth of the global Pertussis Vaccine market?
4. What is the production and production value of the global Pertussis Vaccine market?
5. Who are the key producers in the global Pertussis Vaccine market?
6. What are the growth factors driving the market demand?
In 2024, global Pertussis Vaccine production reached approximately 350 million doses, with an average global market price of around US$ 16 per square meter. Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective. In this report, we cover all the pertussis-containing vaccines. Gross margin for the Pertussis vaccine in general shows that manufacturers often achieve roughly 50–70% gross margins, depending on the producer, country, and contract.
The global pertussis vaccine market continues to grow steadily, driven by rising awareness of whooping cough, expanding childhood immunization programs, and increasing recommendations for adolescent and adult Tdap boosters. Demand is especially strong in developing regions where pertussis remains endemic, while mature markets are supported by routine pregnancy immunization and periodic booster campaigns. Major manufacturers focus on improving vaccine safety, supply stability, and combination formulations such as DTaP, which simplify national immunization schedules. Although pricing and procurement are heavily influenced by government tenders and international organizations, overall market growth is supported by public-health initiatives, technological advances in acellular vaccine production, and efforts to increase global vaccination coverage. The pertussis vaccine industrial chain is a complex, highly regulated, and technology-intensive ecosystem that spans from upstream antigen research to downstream global immunization delivery. It is characterized by significant barriers to entry, stringent quality control, and a delicate balance between public health objectives and commercial viability. The chain begins with basic and applied research into Bordetella pertussis antigens. This includes the identification, genetic sequencing, and optimization of key immunogenic components such as Pertussis Toxin (PT), Filamentous Hemagglutinin (FHA), Pertactin (PRN), and Fimbrial proteins (FIM). For acellular vaccines (aP), the upstream segment involves mastering large-scale fermentation, toxin purification, and detoxification (converting PT to Toxoid) processes. This stage also encompasses the production of specialized adjuvants (e.g., aluminum salts) and critical raw materials for cell culture media and buffers. Innovation here focuses on improving antigen yield, purity, stability, and developing novel adjuvant systems to enhance and prolong immunity. The demand for pertussis vaccines is driven by the persistent prevalence of whooping cough, growing awareness of immunization benefits, and expanding vaccination programs for infants, adolescents, and adults. Rising adoption of Tdap boosters during pregnancy and among healthcare workers further fuels market growth. Opportunities exist in developing countries where vaccination coverage is still limited, as well as in urban areas of developed nations with increasing focus on adult immunization and combination vaccines like DTaP to simplify schedules. Additionally, technological innovations in acellular vaccine production, improvements in cold-chain logistics, and government-supported public health initiatives create potential for new market entrants and partnerships. Manufacturers that can offer safe, effective, and easily deployable vaccines, along with reliable supply chains, are well-positioned to capture market share in both emerging and mature markets.
This report studies the global Pertussis Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pertussis Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pertussis Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pertussis Vaccine total production and demand, 2021-2032, (M Doses)
Global Pertussis Vaccine total production value, 2021-2032, (USD Million)
Global Pertussis Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Doses), (based on production site)
Global Pertussis Vaccine consumption by region & country, CAGR, 2021-2032 & (M Doses)
U.S. VS China: Pertussis Vaccine domestic production, consumption, key domestic manufacturers and share
Global Pertussis Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Doses)
Global Pertussis Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
Global Pertussis Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)
This report profiles key players in the global Pertussis Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pertussis Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/Doses) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pertussis Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- DTaP
- Tdap
- DTwP
- Acellular Vaccines
- Whole-cell Vaccines
- Below 12 Months
- Above 12 Months
- Hospital
- Clinic
- Sanofi Pasteur
- GSK
- Mitsubishi Tanabe Pharma
- KM Biologics
- Wuhan Institute of Biological Products
- Walvax Biotechnology
- Chengdu Institute of Biological Products
- Minhai Biotechnology
1. How big is the global Pertussis Vaccine market?
2. What is the demand of the global Pertussis Vaccine market?
3. What is the year over year growth of the global Pertussis Vaccine market?
4. What is the production and production value of the global Pertussis Vaccine market?
5. Who are the key producers in the global Pertussis Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Pertussis Vaccine Introduction
1.2 World Pertussis Vaccine Supply & Forecast
1.2.1 World Pertussis Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Pertussis Vaccine Production (2021-2032)
1.2.3 World Pertussis Vaccine Pricing Trends (2021-2032)
1.3 World Pertussis Vaccine Production by Region (Based on Production Site)
1.3.1 World Pertussis Vaccine Production Value by Region (2021-2032)
1.3.2 World Pertussis Vaccine Production by Region (2021-2032)
1.3.3 World Pertussis Vaccine Average Price by Region (2021-2032)
1.3.4 North America Pertussis Vaccine Production (2021-2032)
1.3.5 Europe Pertussis Vaccine Production (2021-2032)
1.3.6 China Pertussis Vaccine Production (2021-2032)
1.3.7 Japan Pertussis Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pertussis Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pertussis Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Pertussis Vaccine Demand (2021-2032)
2.2 World Pertussis Vaccine Consumption by Region
2.2.1 World Pertussis Vaccine Consumption by Region (2021-2026)
2.2.2 World Pertussis Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Pertussis Vaccine Consumption (2021-2032)
2.4 China Pertussis Vaccine Consumption (2021-2032)
2.5 Europe Pertussis Vaccine Consumption (2021-2032)
2.6 Japan Pertussis Vaccine Consumption (2021-2032)
2.7 South Korea Pertussis Vaccine Consumption (2021-2032)
2.8 ASEAN Pertussis Vaccine Consumption (2021-2032)
2.9 India Pertussis Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pertussis Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Pertussis Vaccine Production by Manufacturer (2021-2026)
3.3 World Pertussis Vaccine Average Price by Manufacturer (2021-2026)
3.4 Pertussis Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pertussis Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pertussis Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Pertussis Vaccine in 2025
3.6 Pertussis Vaccine Market: Overall Company Footprint Analysis
3.6.1 Pertussis Vaccine Market: Region Footprint
3.6.2 Pertussis Vaccine Market: Company Product Type Footprint
3.6.3 Pertussis Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pertussis Vaccine Production Value Comparison
4.1.1 United States VS China: Pertussis Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Pertussis Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Pertussis Vaccine Production Comparison
4.2.1 United States VS China: Pertussis Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pertussis Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Pertussis Vaccine Consumption Comparison
4.3.1 United States VS China: Pertussis Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Pertussis Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Pertussis Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pertussis Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Pertussis Vaccine Production (2021-2026)
4.5 China Based Pertussis Vaccine Manufacturers and Market Share
4.5.1 China Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pertussis Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Pertussis Vaccine Production (2021-2026)
4.6 Rest of World Based Pertussis Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pertussis Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Pertussis Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Pertussis Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Whole-cell Vaccines
5.2.2 Acellular Vaccines
5.3 Market Segment by Type
5.3.1 World Pertussis Vaccine Production by Type (2021-2032)
5.3.2 World Pertussis Vaccine Production Value by Type (2021-2032)
5.3.3 World Pertussis Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pertussis Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 12 Months Below
6.2.2 12 Months Above
6.3 Market Segment by Application
6.3.1 World Pertussis Vaccine Production by Application (2021-2032)
6.3.2 World Pertussis Vaccine Production Value by Application (2021-2032)
6.3.3 World Pertussis Vaccine Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Details
7.1.2 Sanofi Pasteur Major Business
7.1.3 Sanofi Pasteur Pertussis Vaccine Product and Services
7.1.4 Sanofi Pasteur Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Sanofi Pasteur Recent Developments/Updates
7.1.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Pertussis Vaccine Product and Services
7.2.4 GSK Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Details
7.3.2 Mitsubishi Tanabe Pharma Major Business
7.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Product and Services
7.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.3.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Details
7.4.2 Wuhan Institute of Biological Products Major Business
7.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Product and Services
7.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.4.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Details
7.5.2 Walvax Biotechnology Major Business
7.5.3 Walvax Biotechnology Pertussis Vaccine Product and Services
7.5.4 Walvax Biotechnology Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Walvax Biotechnology Recent Developments/Updates
7.5.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.6 Minhai Biotechnology
7.6.1 Minhai Biotechnology Details
7.6.2 Minhai Biotechnology Major Business
7.6.3 Minhai Biotechnology Pertussis Vaccine Product and Services
7.6.4 Minhai Biotechnology Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Minhai Biotechnology Recent Developments/Updates
7.6.6 Minhai Biotechnology Competitive Strengths & Weaknesses
7.7 KM Biologics
7.7.1 KM Biologics Details
7.7.2 KM Biologics Major Business
7.7.3 KM Biologics Pertussis Vaccine Product and Services
7.7.4 KM Biologics Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 KM Biologics Recent Developments/Updates
7.7.6 KM Biologics Competitive Strengths & Weaknesses
7.8 Chengdu Institute of Biological Products
7.8.1 Chengdu Institute of Biological Products Details
7.8.2 Chengdu Institute of Biological Products Major Business
7.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Product and Services
7.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Chengdu Institute of Biological Products Recent Developments/Updates
7.8.6 Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pertussis Vaccine Industry Chain
8.2 Pertussis Vaccine Upstream Analysis
8.2.1 Pertussis Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Pertussis Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pertussis Vaccine Production Mode
8.6 Pertussis Vaccine Procurement Model
8.7 Pertussis Vaccine Industry Sales Model and Sales Channels
8.7.1 Pertussis Vaccine Sales Model
8.7.2 Pertussis Vaccine Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Pertussis Vaccine Introduction
1.2 World Pertussis Vaccine Supply & Forecast
1.2.1 World Pertussis Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Pertussis Vaccine Production (2021-2032)
1.2.3 World Pertussis Vaccine Pricing Trends (2021-2032)
1.3 World Pertussis Vaccine Production by Region (Based on Production Site)
1.3.1 World Pertussis Vaccine Production Value by Region (2021-2032)
1.3.2 World Pertussis Vaccine Production by Region (2021-2032)
1.3.3 World Pertussis Vaccine Average Price by Region (2021-2032)
1.3.4 North America Pertussis Vaccine Production (2021-2032)
1.3.5 Europe Pertussis Vaccine Production (2021-2032)
1.3.6 China Pertussis Vaccine Production (2021-2032)
1.3.7 Japan Pertussis Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pertussis Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pertussis Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Pertussis Vaccine Demand (2021-2032)
2.2 World Pertussis Vaccine Consumption by Region
2.2.1 World Pertussis Vaccine Consumption by Region (2021-2026)
2.2.2 World Pertussis Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Pertussis Vaccine Consumption (2021-2032)
2.4 China Pertussis Vaccine Consumption (2021-2032)
2.5 Europe Pertussis Vaccine Consumption (2021-2032)
2.6 Japan Pertussis Vaccine Consumption (2021-2032)
2.7 South Korea Pertussis Vaccine Consumption (2021-2032)
2.8 ASEAN Pertussis Vaccine Consumption (2021-2032)
2.9 India Pertussis Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Pertussis Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Pertussis Vaccine Production by Manufacturer (2021-2026)
3.3 World Pertussis Vaccine Average Price by Manufacturer (2021-2026)
3.4 Pertussis Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pertussis Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pertussis Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Pertussis Vaccine in 2025
3.6 Pertussis Vaccine Market: Overall Company Footprint Analysis
3.6.1 Pertussis Vaccine Market: Region Footprint
3.6.2 Pertussis Vaccine Market: Company Product Type Footprint
3.6.3 Pertussis Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Pertussis Vaccine Production Value Comparison
4.1.1 United States VS China: Pertussis Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Pertussis Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Pertussis Vaccine Production Comparison
4.2.1 United States VS China: Pertussis Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Pertussis Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Pertussis Vaccine Consumption Comparison
4.3.1 United States VS China: Pertussis Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Pertussis Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Pertussis Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pertussis Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Pertussis Vaccine Production (2021-2026)
4.5 China Based Pertussis Vaccine Manufacturers and Market Share
4.5.1 China Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pertussis Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Pertussis Vaccine Production (2021-2026)
4.6 Rest of World Based Pertussis Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pertussis Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Pertussis Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Pertussis Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Whole-cell Vaccines
5.2.2 Acellular Vaccines
5.3 Market Segment by Type
5.3.1 World Pertussis Vaccine Production by Type (2021-2032)
5.3.2 World Pertussis Vaccine Production Value by Type (2021-2032)
5.3.3 World Pertussis Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Pertussis Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Application
6.2.1 12 Months Below
6.2.2 12 Months Above
6.3 Market Segment by Application
6.3.1 World Pertussis Vaccine Production by Application (2021-2032)
6.3.2 World Pertussis Vaccine Production Value by Application (2021-2032)
6.3.3 World Pertussis Vaccine Average Price by Application (2021-2032)
7 COMPANY PROFILES
7.1 Sanofi Pasteur
7.1.1 Sanofi Pasteur Details
7.1.2 Sanofi Pasteur Major Business
7.1.3 Sanofi Pasteur Pertussis Vaccine Product and Services
7.1.4 Sanofi Pasteur Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Sanofi Pasteur Recent Developments/Updates
7.1.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.2 GSK
7.2.1 GSK Details
7.2.2 GSK Major Business
7.2.3 GSK Pertussis Vaccine Product and Services
7.2.4 GSK Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 GSK Recent Developments/Updates
7.2.6 GSK Competitive Strengths & Weaknesses
7.3 Mitsubishi Tanabe Pharma
7.3.1 Mitsubishi Tanabe Pharma Details
7.3.2 Mitsubishi Tanabe Pharma Major Business
7.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Product and Services
7.3.4 Mitsubishi Tanabe Pharma Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
7.3.6 Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Details
7.4.2 Wuhan Institute of Biological Products Major Business
7.4.3 Wuhan Institute of Biological Products Pertussis Vaccine Product and Services
7.4.4 Wuhan Institute of Biological Products Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Wuhan Institute of Biological Products Recent Developments/Updates
7.4.6 Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Details
7.5.2 Walvax Biotechnology Major Business
7.5.3 Walvax Biotechnology Pertussis Vaccine Product and Services
7.5.4 Walvax Biotechnology Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Walvax Biotechnology Recent Developments/Updates
7.5.6 Walvax Biotechnology Competitive Strengths & Weaknesses
7.6 Minhai Biotechnology
7.6.1 Minhai Biotechnology Details
7.6.2 Minhai Biotechnology Major Business
7.6.3 Minhai Biotechnology Pertussis Vaccine Product and Services
7.6.4 Minhai Biotechnology Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 Minhai Biotechnology Recent Developments/Updates
7.6.6 Minhai Biotechnology Competitive Strengths & Weaknesses
7.7 KM Biologics
7.7.1 KM Biologics Details
7.7.2 KM Biologics Major Business
7.7.3 KM Biologics Pertussis Vaccine Product and Services
7.7.4 KM Biologics Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 KM Biologics Recent Developments/Updates
7.7.6 KM Biologics Competitive Strengths & Weaknesses
7.8 Chengdu Institute of Biological Products
7.8.1 Chengdu Institute of Biological Products Details
7.8.2 Chengdu Institute of Biological Products Major Business
7.8.3 Chengdu Institute of Biological Products Pertussis Vaccine Product and Services
7.8.4 Chengdu Institute of Biological Products Pertussis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Chengdu Institute of Biological Products Recent Developments/Updates
7.8.6 Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Pertussis Vaccine Industry Chain
8.2 Pertussis Vaccine Upstream Analysis
8.2.1 Pertussis Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Pertussis Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pertussis Vaccine Production Mode
8.6 Pertussis Vaccine Procurement Model
8.7 Pertussis Vaccine Industry Sales Model and Sales Channels
8.7.1 Pertussis Vaccine Sales Model
8.7.2 Pertussis Vaccine Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Pertussis Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Pertussis Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Pertussis Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Pertussis Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Pertussis Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Pertussis Vaccine Production by Region (2021-2026) & (M Doses)
Table 7. World Pertussis Vaccine Production by Region (2027-2032) & (M Doses)
Table 8. World Pertussis Vaccine Production Market Share by Region (2021-2026)
Table 9. World Pertussis Vaccine Production Market Share by Region (2027-2032)
Table 10. World Pertussis Vaccine Average Price by Region (2021-2026) & (USD/Doses)
Table 11. World Pertussis Vaccine Average Price by Region (2027-2032) & (USD/Doses)
Table 12. Pertussis Vaccine Major Market Trends
Table 13. World Pertussis Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Doses)
Table 14. World Pertussis Vaccine Consumption by Region (2021-2026) & (M Doses)
Table 15. World Pertussis Vaccine Consumption Forecast by Region (2027-2032) & (M Doses)
Table 16. World Pertussis Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Pertussis Vaccine Producers in 2025
Table 18. World Pertussis Vaccine Production by Manufacturer (2021-2026) & (M Doses)
Table 19. Production Market Share of Key Pertussis Vaccine Producers in 2025
Table 20. World Pertussis Vaccine Average Price by Manufacturer (2021-2026) & (USD/Doses)
Table 21. Global Pertussis Vaccine Company Evaluation Quadrant
Table 22. World Pertussis Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Pertussis Vaccine Production Site of Key Manufacturer
Table 24. Pertussis Vaccine Market: Company Product Type Footprint
Table 25. Pertussis Vaccine Market: Company Product Application Footprint
Table 26. Pertussis Vaccine Competitive Factors
Table 27. Pertussis Vaccine New Entrant and Capacity Expansion Plans
Table 28. Pertussis Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Pertussis Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Pertussis Vaccine Production Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 31. United States VS China Pertussis Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 32. United States Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pertussis Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Pertussis Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Pertussis Vaccine Production (2021-2026) & (M Doses)
Table 36. United States Based Manufacturers Pertussis Vaccine Production Market Share (2021-2026)
Table 37. China Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pertussis Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Pertussis Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Pertussis Vaccine Production, (2021-2026) & (M Doses)
Table 41. China Based Manufacturers Pertussis Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Pertussis Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Pertussis Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Pertussis Vaccine Production, (2021-2026) & (M Doses)
Table 46. Rest of World Based Manufacturers Pertussis Vaccine Production Market Share (2021-2026)
Table 47. World Pertussis Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Pertussis Vaccine Production by Type (2021-2026) & (M Doses)
Table 49. World Pertussis Vaccine Production by Type (2027-2032) & (M Doses)
Table 50. World Pertussis Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Pertussis Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Pertussis Vaccine Average Price by Type (2021-2026) & (USD/Doses)
Table 53. World Pertussis Vaccine Average Price by Type (2027-2032) & (USD/Doses)
Table 54. World Pertussis Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Pertussis Vaccine Production by Application (2021-2026) & (M Doses)
Table 56. World Pertussis Vaccine Production by Application (2027-2032) & (M Doses)
Table 57. World Pertussis Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 58. World Pertussis Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 59. World Pertussis Vaccine Average Price by Application (2021-2026) & (USD/Doses)
Table 60. World Pertussis Vaccine Average Price by Application (2027-2032) & (USD/Doses)
Table 61. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Pasteur Major Business
Table 63. Sanofi Pasteur Pertussis Vaccine Product and Services
Table 64. Sanofi Pasteur Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sanofi Pasteur Recent Developments/Updates
Table 66. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Pertussis Vaccine Product and Services
Table 70. GSK Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Mitsubishi Tanabe Pharma Major Business
Table 75. Mitsubishi Tanabe Pharma Pertussis Vaccine Product and Services
Table 76. Mitsubishi Tanabe Pharma Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 78. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 79. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 80. Wuhan Institute of Biological Products Major Business
Table 81. Wuhan Institute of Biological Products Pertussis Vaccine Product and Services
Table 82. Wuhan Institute of Biological Products Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Wuhan Institute of Biological Products Recent Developments/Updates
Table 84. Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
Table 85. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 86. Walvax Biotechnology Major Business
Table 87. Walvax Biotechnology Pertussis Vaccine Product and Services
Table 88. Walvax Biotechnology Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Walvax Biotechnology Recent Developments/Updates
Table 90. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 91. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 92. Minhai Biotechnology Major Business
Table 93. Minhai Biotechnology Pertussis Vaccine Product and Services
Table 94. Minhai Biotechnology Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Minhai Biotechnology Recent Developments/Updates
Table 96. Minhai Biotechnology Competitive Strengths & Weaknesses
Table 97. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 98. KM Biologics Major Business
Table 99. KM Biologics Pertussis Vaccine Product and Services
Table 100. KM Biologics Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. KM Biologics Recent Developments/Updates
Table 102. KM Biologics Competitive Strengths & Weaknesses
Table 103. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 104. Chengdu Institute of Biological Products Major Business
Table 105. Chengdu Institute of Biological Products Pertussis Vaccine Product and Services
Table 106. Chengdu Institute of Biological Products Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Chengdu Institute of Biological Products Recent Developments/Updates
Table 108. Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
Table 109. Global Key Players of Pertussis Vaccine Upstream (Raw Materials)
Table 110. Global Pertussis Vaccine Typical Customers
Table 111. Pertussis Vaccine Typical Distributors
Table 1. World Pertussis Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Pertussis Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Pertussis Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Pertussis Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Pertussis Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Pertussis Vaccine Production by Region (2021-2026) & (M Doses)
Table 7. World Pertussis Vaccine Production by Region (2027-2032) & (M Doses)
Table 8. World Pertussis Vaccine Production Market Share by Region (2021-2026)
Table 9. World Pertussis Vaccine Production Market Share by Region (2027-2032)
Table 10. World Pertussis Vaccine Average Price by Region (2021-2026) & (USD/Doses)
Table 11. World Pertussis Vaccine Average Price by Region (2027-2032) & (USD/Doses)
Table 12. Pertussis Vaccine Major Market Trends
Table 13. World Pertussis Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Doses)
Table 14. World Pertussis Vaccine Consumption by Region (2021-2026) & (M Doses)
Table 15. World Pertussis Vaccine Consumption Forecast by Region (2027-2032) & (M Doses)
Table 16. World Pertussis Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Pertussis Vaccine Producers in 2025
Table 18. World Pertussis Vaccine Production by Manufacturer (2021-2026) & (M Doses)
Table 19. Production Market Share of Key Pertussis Vaccine Producers in 2025
Table 20. World Pertussis Vaccine Average Price by Manufacturer (2021-2026) & (USD/Doses)
Table 21. Global Pertussis Vaccine Company Evaluation Quadrant
Table 22. World Pertussis Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Pertussis Vaccine Production Site of Key Manufacturer
Table 24. Pertussis Vaccine Market: Company Product Type Footprint
Table 25. Pertussis Vaccine Market: Company Product Application Footprint
Table 26. Pertussis Vaccine Competitive Factors
Table 27. Pertussis Vaccine New Entrant and Capacity Expansion Plans
Table 28. Pertussis Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Pertussis Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Pertussis Vaccine Production Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 31. United States VS China Pertussis Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (M Doses)
Table 32. United States Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pertussis Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Pertussis Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Pertussis Vaccine Production (2021-2026) & (M Doses)
Table 36. United States Based Manufacturers Pertussis Vaccine Production Market Share (2021-2026)
Table 37. China Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pertussis Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Pertussis Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Pertussis Vaccine Production, (2021-2026) & (M Doses)
Table 41. China Based Manufacturers Pertussis Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Pertussis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Pertussis Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Pertussis Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Pertussis Vaccine Production, (2021-2026) & (M Doses)
Table 46. Rest of World Based Manufacturers Pertussis Vaccine Production Market Share (2021-2026)
Table 47. World Pertussis Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Pertussis Vaccine Production by Type (2021-2026) & (M Doses)
Table 49. World Pertussis Vaccine Production by Type (2027-2032) & (M Doses)
Table 50. World Pertussis Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Pertussis Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Pertussis Vaccine Average Price by Type (2021-2026) & (USD/Doses)
Table 53. World Pertussis Vaccine Average Price by Type (2027-2032) & (USD/Doses)
Table 54. World Pertussis Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 55. World Pertussis Vaccine Production by Application (2021-2026) & (M Doses)
Table 56. World Pertussis Vaccine Production by Application (2027-2032) & (M Doses)
Table 57. World Pertussis Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 58. World Pertussis Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 59. World Pertussis Vaccine Average Price by Application (2021-2026) & (USD/Doses)
Table 60. World Pertussis Vaccine Average Price by Application (2027-2032) & (USD/Doses)
Table 61. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Pasteur Major Business
Table 63. Sanofi Pasteur Pertussis Vaccine Product and Services
Table 64. Sanofi Pasteur Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Sanofi Pasteur Recent Developments/Updates
Table 66. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 67. GSK Basic Information, Manufacturing Base and Competitors
Table 68. GSK Major Business
Table 69. GSK Pertussis Vaccine Product and Services
Table 70. GSK Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. GSK Recent Developments/Updates
Table 72. GSK Competitive Strengths & Weaknesses
Table 73. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 74. Mitsubishi Tanabe Pharma Major Business
Table 75. Mitsubishi Tanabe Pharma Pertussis Vaccine Product and Services
Table 76. Mitsubishi Tanabe Pharma Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 78. Mitsubishi Tanabe Pharma Competitive Strengths & Weaknesses
Table 79. Wuhan Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 80. Wuhan Institute of Biological Products Major Business
Table 81. Wuhan Institute of Biological Products Pertussis Vaccine Product and Services
Table 82. Wuhan Institute of Biological Products Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Wuhan Institute of Biological Products Recent Developments/Updates
Table 84. Wuhan Institute of Biological Products Competitive Strengths & Weaknesses
Table 85. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 86. Walvax Biotechnology Major Business
Table 87. Walvax Biotechnology Pertussis Vaccine Product and Services
Table 88. Walvax Biotechnology Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Walvax Biotechnology Recent Developments/Updates
Table 90. Walvax Biotechnology Competitive Strengths & Weaknesses
Table 91. Minhai Biotechnology Basic Information, Manufacturing Base and Competitors
Table 92. Minhai Biotechnology Major Business
Table 93. Minhai Biotechnology Pertussis Vaccine Product and Services
Table 94. Minhai Biotechnology Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Minhai Biotechnology Recent Developments/Updates
Table 96. Minhai Biotechnology Competitive Strengths & Weaknesses
Table 97. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 98. KM Biologics Major Business
Table 99. KM Biologics Pertussis Vaccine Product and Services
Table 100. KM Biologics Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. KM Biologics Recent Developments/Updates
Table 102. KM Biologics Competitive Strengths & Weaknesses
Table 103. Chengdu Institute of Biological Products Basic Information, Manufacturing Base and Competitors
Table 104. Chengdu Institute of Biological Products Major Business
Table 105. Chengdu Institute of Biological Products Pertussis Vaccine Product and Services
Table 106. Chengdu Institute of Biological Products Pertussis Vaccine Production (M Doses), Price (USD/Doses), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Chengdu Institute of Biological Products Recent Developments/Updates
Table 108. Chengdu Institute of Biological Products Competitive Strengths & Weaknesses
Table 109. Global Key Players of Pertussis Vaccine Upstream (Raw Materials)
Table 110. Global Pertussis Vaccine Typical Customers
Table 111. Pertussis Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Pertussis Vaccine Picture
Figure 2. World Pertussis Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pertussis Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Pertussis Vaccine Production (2021-2032) & (M Doses)
Figure 5. World Pertussis Vaccine Average Price (2021-2032) & (USD/Doses)
Figure 6. World Pertussis Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Pertussis Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Pertussis Vaccine Production (2021-2032) & (M Doses)
Figure 9. Europe Pertussis Vaccine Production (2021-2032) & (M Doses)
Figure 10. China Pertussis Vaccine Production (2021-2032) & (M Doses)
Figure 11. Japan Pertussis Vaccine Production (2021-2032) & (M Doses)
Figure 12. Pertussis Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 15. World Pertussis Vaccine Consumption Market Share by Region (2021-2032)
Figure 16. United States Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 17. China Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 18. Europe Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 19. Japan Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 20. South Korea Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 21. ASEAN Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 22. India Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 23. Producer Shipments of Pertussis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pertussis Vaccine Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pertussis Vaccine Markets in 2025
Figure 26. United States VS China: Pertussis Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Pertussis Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Pertussis Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Pertussis Vaccine Production Market Share 2025
Figure 30. China Based Manufacturers Pertussis Vaccine Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Pertussis Vaccine Production Market Share 2025
Figure 32. World Pertussis Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Pertussis Vaccine Production Value Market Share by Type in 2025
Figure 34. Whole-cell Vaccines
Figure 35. Acellular Vaccines
Figure 36. World Pertussis Vaccine Production Market Share by Type (2021-2032)
Figure 37. World Pertussis Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World Pertussis Vaccine Average Price by Type (2021-2032) & (USD/Doses)
Figure 39. World Pertussis Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 40. World Pertussis Vaccine Production Value Market Share by Application in 2025
Figure 41. 12 Months Below
Figure 42. 12 Months Above
Figure 43. World Pertussis Vaccine Production Market Share by Application (2021-2032)
Figure 44. World Pertussis Vaccine Production Value Market Share by Application (2021-2032)
Figure 45. World Pertussis Vaccine Average Price by Application (2021-2032) & (USD/Doses)
Figure 46. Pertussis Vaccine Industry Chain
Figure 47. Pertussis Vaccine Procurement Model
Figure 48. Pertussis Vaccine Sales Model
Figure 49. Pertussis Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Pertussis Vaccine Picture
Figure 2. World Pertussis Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Pertussis Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Pertussis Vaccine Production (2021-2032) & (M Doses)
Figure 5. World Pertussis Vaccine Average Price (2021-2032) & (USD/Doses)
Figure 6. World Pertussis Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Pertussis Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Pertussis Vaccine Production (2021-2032) & (M Doses)
Figure 9. Europe Pertussis Vaccine Production (2021-2032) & (M Doses)
Figure 10. China Pertussis Vaccine Production (2021-2032) & (M Doses)
Figure 11. Japan Pertussis Vaccine Production (2021-2032) & (M Doses)
Figure 12. Pertussis Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 15. World Pertussis Vaccine Consumption Market Share by Region (2021-2032)
Figure 16. United States Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 17. China Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 18. Europe Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 19. Japan Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 20. South Korea Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 21. ASEAN Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 22. India Pertussis Vaccine Consumption (2021-2032) & (M Doses)
Figure 23. Producer Shipments of Pertussis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pertussis Vaccine Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pertussis Vaccine Markets in 2025
Figure 26. United States VS China: Pertussis Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Pertussis Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Pertussis Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Pertussis Vaccine Production Market Share 2025
Figure 30. China Based Manufacturers Pertussis Vaccine Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Pertussis Vaccine Production Market Share 2025
Figure 32. World Pertussis Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Pertussis Vaccine Production Value Market Share by Type in 2025
Figure 34. Whole-cell Vaccines
Figure 35. Acellular Vaccines
Figure 36. World Pertussis Vaccine Production Market Share by Type (2021-2032)
Figure 37. World Pertussis Vaccine Production Value Market Share by Type (2021-2032)
Figure 38. World Pertussis Vaccine Average Price by Type (2021-2032) & (USD/Doses)
Figure 39. World Pertussis Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 40. World Pertussis Vaccine Production Value Market Share by Application in 2025
Figure 41. 12 Months Below
Figure 42. 12 Months Above
Figure 43. World Pertussis Vaccine Production Market Share by Application (2021-2032)
Figure 44. World Pertussis Vaccine Production Value Market Share by Application (2021-2032)
Figure 45. World Pertussis Vaccine Average Price by Application (2021-2032) & (USD/Doses)
Figure 46. Pertussis Vaccine Industry Chain
Figure 47. Pertussis Vaccine Procurement Model
Figure 48. Pertussis Vaccine Sales Model
Figure 49. Pertussis Vaccine Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
